Todos Medical (TOMDF) Ratios
Todos Medical Ratios
TOMDF's free cash flow for Q4 2022 was $883.90K. For the 2022 fiscal year, TOMDF's free cash flow was increased by $1.68M and operating cash flow was $-796.96K. See a summary of the company’s cash flow.
| Ratios | Dec 22 | Mar 22 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.20 | 0.53 | 0.30 | 0.02 | 0.09 |
| Quick Ratio | 0.14 | 0.35 | 0.24 | 0.02 | 0.09 |
| Cash Ratio | 0.00 | 0.02 | 0.12 | 0.01 | 0.05 |
| Solvency Ratio | -0.48 | -1.08 | -1.74 | -1.54 | -0.31 |
| Operating Cash Flow Ratio | -0.16 | -1.25 | -0.32 | -0.82 | -0.88 |
| Short-Term Operating Cash Flow Coverage | -0.51 | -5.55 | -0.86 | -11.33 | -1.65 |
| Net Current Asset Value | $ -46.78M | $ -34.61M | $ -14.57M | $ -6.31M | $ -1.31M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 2.51 | 2.10 | 1.90 | 42.36 | 3.16 |
| Debt-to-Equity Ratio | -1.08 | -1.31 | -1.04 | -0.62 | -0.52 |
| Debt-to-Capital Ratio | 13.52 | 4.21 | 26.49 | -1.61 | -1.07 |
| Long-Term Debt-to-Capital Ratio | -13.14 | 5.50 | -3.32 | -1.49 | 0.00 |
| Financial Leverage Ratio | -0.43 | -0.62 | -0.55 | -0.01 | -0.16 |
| Debt Service Coverage Ratio | -0.47 | -0.29 | -3.86 | -5.39 | -2.12 |
| Interest Coverage Ratio | -0.66 | -0.30 | -4.08 | -3.67 | 0.00 |
| Debt to Market Cap | 3.02 | 0.80 | 0.59 | 1.05 | 0.06 |
| Interest Debt Per Share | 0.04 | 0.09 | 0.06 | 0.05 | 0.01 |
| Net Debt to EBITDA | -4.08 | -3.25 | -0.42 | -0.49 | -0.42 |
| Profitability Margins | |||||
| Gross Profit Margin | 56.01% | 35.84% | 26.68% | 0.00% | 0.00% |
| EBIT Margin | -131.83% | -85.67% | -481.62% | 0.00% | 0.00% |
| EBITDA Margin | -122.08% | -79.44% | -479.78% | 0.00% | 0.00% |
| Operating Profit Margin | -126.68% | -75.93% | -273.88% | 0.00% | 0.00% |
| Pretax Profit Margin | -324.64% | -354.16% | -571.79% | 0.00% | 0.00% |
| Net Profit Margin | -324.81% | -354.16% | -571.79% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -324.64% | -354.16% | -571.79% | 0.00% | 0.00% |
| Net Income Per EBT | 100.05% | 100.00% | 100.00% | 83.01% | 100.00% |
| EBT Per EBIT | 256.27% | 466.44% | 208.77% | 336.10% | 33.18% |
| Return on Assets (ROA) | -163.71% | -286.56% | -495.47% | -10789.16% | -229.78% |
| Return on Equity (ROE) | 70.38% | 178.89% | 270.39% | 156.95% | 37.63% |
| Return on Capital Employed (ROCE) | 748.69% | -150.87% | 692.28% | 239.00% | 137.97% |
| Return on Invested Capital (ROIC) | -243.76% | -113.55% | -1553.49% | 214.85% | 382.51% |
| Return on Tangible Assets | -1872.21% | -585.40% | -495.47% | -10789.16% | -229.78% |
| Earnings Yield | -196.99% | -109.89% | -153.17% | -266.44% | -4.30% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.34 | 4.85 | 13.78 | 0.00 | 0.00 |
| Payables Turnover | 0.51 | 3.45 | 2.33 | 0.07 | 0.16 |
| Inventory Turnover | 3.32 | 4.90 | 7.12 | 0.00 | 0.00 |
| Fixed Asset Turnover | 5.35 | 5.59 | 2.60 | 0.00 | 0.00 |
| Asset Turnover | 0.50 | 0.81 | 0.87 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | -0.88 | -2.48 | -1.46 | 0.00 | 0.00 |
| Cash Conversion Cycle | -552.19 | 43.90 | -79.05 | -5103.33 | -2321.97 |
| Days of Sales Outstanding | 49.71 | 75.21 | 26.50 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 110.09 | 74.56 | 51.24 | 0.00 | 0.00 |
| Days of Payables Outstanding | 711.99 | 105.87 | 156.78 | 5103.33 | 2321.97 |
| Operating Cycle | 159.80 | 149.77 | 77.74 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.02 | -0.01 | -0.01 | -0.01 |
| Free Cash Flow Per Share | -0.00 | -0.02 | -0.02 | -0.01 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | -36.66 | -10.23 | -1.03 | -1189.41 | -68.72 |
| Capital Expenditure Coverage Ratio | -36.66 | -10.23 | -1.03 | -1189.41 | -68.72 |
| Operating Cash Flow Coverage Ratio | -0.07 | -0.35 | -0.22 | -0.33 | -1.68 |
| Operating Cash Flow to Sales Ratio | -0.35 | -0.92 | -0.49 | 0.00 | 0.00 |
| Free Cash Flow Yield | -21.97% | -31.26% | -25.92% | -34.70% | -10.08% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.51 | -0.91 | -0.65 | -0.38 | -23.23 |
| Price-to-Sales (P/S) Ratio | 1.65 | 3.22 | 3.73 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.36 | -1.63 | -1.77 | -0.59 | -8.74 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.55 | -3.20 | -3.86 | -2.88 | -9.92 |
| Price-to-Operating Cash Flow Ratio | -4.68 | -3.51 | -7.60 | -2.88 | -10.06 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.02 | 0.00 | -0.00 | 0.28 |
| Enterprise Value Multiple | -5.43 | -7.31 | -1.20 | -0.97 | -8.27 |
| Enterprise Value | 51.00M | 70.98M | 29.95M | 7.52M | 11.20M |
| EV to EBITDA | -5.43 | -7.31 | -1.20 | -0.97 | -8.27 |
| EV to Sales | 6.63 | 5.80 | 5.75 | 0.00 | 0.00 |
| EV to Free Cash Flow | -18.30 | -5.76 | -5.94 | -5.89 | -10.45 |
| EV to Operating Cash Flow | -18.80 | -6.32 | -11.71 | -5.89 | -10.60 |
| Tangible Book Value Per Share | -0.03 | -0.05 | -0.04 | -0.07 | -0.02 |
| Shareholders’ Equity Per Share | -0.02 | -0.04 | -0.04 | -0.07 | -0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.17 | 0.00 |
| Revenue Per Share | 0.01 | 0.02 | 0.02 | 0.00 | 0.00 |
| Net Income Per Share | -0.02 | -0.06 | -0.11 | -0.11 | -0.01 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.83 | 1.00 |
| Interest Burden | 2.46 | 4.13 | 1.19 | 1.51 | 1.00 |
| Research & Development to Revenue | 0.08 | 0.07 | 1.89 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.77 | 0.52 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.10 | 0.50 | 0.00 | 0.00 |
| Income Quality | 0.11 | 0.26 | 0.09 | 0.11 | 2.31 |
Currency in USD
